SBE — Leo International Precision Health AG Cashflow Statement
0.000.00%
- €4.93m
- €5.06m
Annual cashflow statement for Leo International Precision Health AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | GAS | GAS | GAS | GAS | GAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.064 | -0.048 | -0.072 | -0.122 | -0.149 |
Non-Cash Items | 0 | 0 | 0 | 0.002 | 0 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.004 | 0.004 | 0.025 | 0.037 | 0.042 |
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.06 | -0.044 | -0.047 | -0.083 | -0.107 |
Financing Cash Flow Items | 0.056 | 0.046 | 0.046 | 0.03 | 0.001 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.056 | 0.046 | 0.046 | 0.086 | 0.101 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.005 | 0.002 | -0.001 | 0.002 | -0.005 |